CAS 3569-10-6: (-)-Valerenic acid
Formula:C15H22O2
InChI:InChI=1S/C15H22O2/c1-9-4-6-12(8-11(3)15(16)17)14-10(2)5-7-13(9)14/h8-9,12-13H,4-7H2,1-3H3,(H,16,17)/b11-8+/t9-,12+,13-/m1/s1
InChI key:InChIKey=FEBNTWHYQKGEIQ-SUKRRCERSA-N
SMILES:C(=C(/C(O)=O)\C)\[C@H]1C=2[C@](CCC2C)([C@H](C)CC1)[H]
Synonyms:- (2E)-3-(3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl)-2-methylprop-2-enoic acid
- (2E)-3-[(4S,7R,7aR)-2,4,5,6,7,7a-Hexahydro-3,7-dimethyl-1H-inden-4-yl]-2-methyl-2-propenoic acid
- (2E)-3-[(4S,7R,7aR)-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid
- (2Z)-3-[(4S,7R,7aR)-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid
- 2-Propenoic acid, 3-(2,4,5,6,7,7a-hexahydro-3,7-dimethyl-1H-inden-4-yl)-2-methyl-, (4S-(4alpha(E),7beta,7aalpha))-
- 2-Propenoic acid, 3-(2,4,5,6,7,7a-hexahydro-3,7-dimethyl-1H-inden-4-yl)-2-methyl-, [4S-[4α(E),7β,7aα]]-
- 2-Propenoic acid, 3-[(4S,7R,7aR)-2,4,5,6,7,7a-hexahydro-3,7-dimethyl-1H-inden-4-yl]-2-methyl-, (2E)-
- Indene-4-acrylic acid, 2,4,5,6,7,7a-hexahydro-α,3,7-trimethyl-
- Nardin
- Valerenic acid
Sort by
Found 9 products.
(-)-Valerenic Acid
CAS:Controlled ProductApplications Valerenic Acid, acts as a subtype-selective GABAA receptor agonist in neonatal rat brainstem preparations. It can be used for the synthesis of Valerena-4,7(11)-diene, a highly active sedative. References Yuan, C. S., et al.: Anesthesia and Analgesia, 98, 353 (2004); Dietz, B., et al.: Mol. Brain Res., 138, 191 (2005); Kitayama, T., et al.: Biosci. Biotechnol. Biochem., 74 (9), 1963 (2010);Formula:C15H22O2Color and Shape:NeatMolecular weight:234.33Valerenic acid - Valeriana officinalis (common valerian)
CAS:Valerenic acid is a bioactive compound, which is a sesquiterpenoid product of Valeriana officinalis, commonly known as valerian. This perennial flowering plant is native to Europe and parts of Asia and has been employed in traditional medicine for centuries. Valerenic acid is primarily extracted from the root, which is known for its distinctive aroma and therapeutic properties. The mode of action of valerenic acid involves modulation of the gamma-aminobutyric acid (GABA) system, which is the primary inhibitory neurotransmitter system in the human central nervous system. By enhancing GABAergic transmission, valerenic acid may exert anxiolytic and sedative effects, which contribute to its efficacy as a calming agent. The principal uses and applications of valerenic acid include its incorporation into treatments aimed at alleviating anxiety and insomnia. Additionally, its soothing properties make it a potential candidate for adjunctive therapy in managing stress and related disorders. Scientists continue to investigate its pharmacodynamics and pharmacokinetics, aiming to elucidate its therapeutic potential and optimize its use in clinical settings.Formula:C15H22O2Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:234.33 g/molValerenic Acid
CAS:Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFormula:C15H22O2Color and Shape:White CrystalsMolecular weight:234.16198Valerenic acid
CAS:Valerenic acid analytical standard provided with w/w absolute assay, to be used for quantitative titration.Formula:C15H22O2Purity:(HPLC) ≥98%Color and Shape:PowderMolecular weight:234.35Valerenic acid
CAS:Alicyclic monobasic carboxylic acidFormula:C15H22O2Purity:≥ 95.0 % (HPLC)Color and Shape:PowderMolecular weight:234.34Valerenic acid
CAS:Valerenic acid is a natural productFormula:C15H22O2Purity:98%Color and Shape:Brown-Yellow PowderMolecular weight:234.3
